B. Schwarz

发表

Bedeutung mesenchymaler Stammzellen in der Viszeralmedizin Significance of Mesenchymal Stem Cells in Gastrointestinal Disorders

Y. Zhao, P. Nelson, C. Bruns, 2015 .

Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation

M. Reiser, M. Ingrisch, K. Nikolaou, 2013, PloS one.

In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media

M. Reiser, O. Dietrich, S. Sourbron, 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

Selective Targeting of Genetically Engineered Mesenchymal Stem Cells to Tumor Stroma Microenvironments Using Tissue-Specific Suicide Gene Expression Suppresses Growth of Hepatocellular Carcinoma

F. Schwab, P. Nelson, M. Notohamiprodjo, 2011, Annals of surgery.

Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study.

M. Reiser, O. Dietrich, S. Sourbron, 2012, AJR. American journal of roentgenology.

Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling

M. Guba, K. Jauch, C. Graeb, 2008, Oncogene.

Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.

P. Nelson, K. Jauch, C. Conrad, 2012, Stem cells and development.

BRCA2 Mutation as a Possible Cause of Poor Response to 177Lu-PSMA Therapy.

M. Essler, H. Ahmadzadehfar, F. Gaertner, 2018, Clinical nuclear medicine.

Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer

J. Ellwart, K. Jauch, Yan Wang, 2015, Targeted Oncology.

Targeting the vasculature of visceral tumors: novel insights and treatment perspectives

K. Jauch, C. Bruns, M. Angele, 2012, Langenbeck's Archives of Surgery.

Stem Cell-Like Side Populations in Esophageal Cancer : A Source of Chemotherapy Resistance and Metastases

J. Izbicki, P. Nelson, S. Gros, 2014 .

KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer

V. Heinemann, A. Jung, R. Laubender, 2013, Journal of Cancer Research and Clinical Oncology.

What We Know about Carcinogenesis of Ductal Adenocarcinoma of the Pancreas

C. Bruns, M. Angele, A. Kleespies, 2015 .

Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells

P. Nelson, R. Hartig, J. Ellwart, 2016, International journal of oncology.

Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients

M. Guba, K. Jauch, C. Graeb, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Dynamic Contrast-Enhanced Computed Tomography Imaging Biomarkers Correlated With Immunohistochemistry for Monitoring the Effects of Sorafenib on Experimental Prostate Carcinomas

Konstantin Nikolaou, Olaf Dietrich, Michael Ingrisch, 2012, Investigative radiology.

Combination of 177Lu-PSMA-617 and External Radiotherapy for the Treatment of Cerebral Metastases in Patients With Castration-Resistant Metastatic Prostate Cancer.

M. Essler, H. Ahmadzadehfar, C. Schlenkhoff, 2017, Clinical nuclear medicine.

Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin

Y. Zhao, P. Nelson, K. Jauch, 2013, Targeted Oncology.

BRCA2 Mutation as a Possible Cause of Poor Response to 177Lu-PSMA Therapy.

M. Essler, H. Ahmadzadehfar, F. Gaertner, 2018, Clinical nuclear medicine.

Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.

P. Nelson, K. Jauch, C. Conrad, 2012, Stem cells and development.